anmelden
OMX Nordic 40
2.707,24
PKT
-25,85
PKT
-0,95
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.09.24 | Novo Nordisk Neutral | UBS AG | |
| 11.09.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 10.09.24 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 03.09.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.24 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.08.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 27.08.24 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 14.08.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
| 13.08.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 09.08.24 | Novo Nordisk Neutral | UBS AG | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Neutral | UBS AG | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.08.24 | Novo Nordisk Neutral | UBS AG | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.24 | Volvo (B) Sector Perform | RBC Capital Markets |
